Screening of Parkinson's Differential MicroRNA Based on GEO Database and Its Clinical Verification. 2021

Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
Department of Neurology, Ganzhou People's Hospital, Ganzhou 341000, Jiangxi Province, China.

OBJECTIVE This study is set out to explore the potential difference of miR in PD through GEO data and provide diagnostic indicators for clinical practice. METHODS In this study, differential miR was screened through the Gene Expression Omnibus (GEO) database, 68 PD patients treated in our hospital from May 2017 to March 2018 were collected as the research group (RG), and 50 normal subjects who underwent physical examination in our hospital during the same period were collected as the control group (CG). Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression and diagnostic value of miR-374a-5p in serum of patients. The potential target genes of miR-374a-5p were predicted, and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and Gene Ontology Consortium (GO) were carried out. RESULTS GEO2R analysis revealed that 193 miRs are expressed differentially, of which 78 were highly expressed and 115 were poorly expressed. The miR-374a-5p expression in the serum of the RG was reduced markedly and had a diagnostic value. Targetscan and miRDB online websites were used to predict their target genes, with 415 common target genes. miR-374a-5p may participate in 27 functional pathways and 8 signal pathways. CONCLUSIONS miR-335-5p has low expression in PD and is expected to be a potential diagnostic indicator.

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D019295 Computational Biology A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories for solving biological problems including manipulation of models and datasets. Bioinformatics,Molecular Biology, Computational,Bio-Informatics,Biology, Computational,Computational Molecular Biology,Bio Informatics,Bio-Informatic,Bioinformatic,Biologies, Computational Molecular,Biology, Computational Molecular,Computational Molecular Biologies,Molecular Biologies, Computational
D020411 Oligonucleotide Array Sequence Analysis Hybridization of a nucleic acid sample to a very large set of OLIGONUCLEOTIDE PROBES, which have been attached individually in columns and rows to a solid support, to determine a BASE SEQUENCE, or to detect variations in a gene sequence, GENE EXPRESSION, or for GENE MAPPING. DNA Microarrays,Gene Expression Microarray Analysis,Oligonucleotide Arrays,cDNA Microarrays,DNA Arrays,DNA Chips,DNA Microchips,Gene Chips,Oligodeoxyribonucleotide Array Sequence Analysis,Oligonucleotide Microarrays,Sequence Analysis, Oligonucleotide Array,cDNA Arrays,Array, DNA,Array, Oligonucleotide,Array, cDNA,Arrays, DNA,Arrays, Oligonucleotide,Arrays, cDNA,Chip, DNA,Chip, Gene,Chips, DNA,Chips, Gene,DNA Array,DNA Chip,DNA Microarray,DNA Microchip,Gene Chip,Microarray, DNA,Microarray, Oligonucleotide,Microarray, cDNA,Microarrays, DNA,Microarrays, Oligonucleotide,Microarrays, cDNA,Microchip, DNA,Microchips, DNA,Oligonucleotide Array,Oligonucleotide Microarray,cDNA Array,cDNA Microarray
D030561 Databases, Nucleic Acid Databases containing information about NUCLEIC ACIDS such as BASE SEQUENCE; SNPS; NUCLEIC ACID CONFORMATION; and other properties. Information about the DNA fragments kept in a GENE LIBRARY or GENOMIC LIBRARY is often maintained in DNA databases. DDBJ,DNA Data Bank of Japan,DNA Data Banks,DNA Databases,Databases, DNA,Databases, DNA Sequence,Databases, Nucleic Acid Sequence,Databases, RNA,Databases, RNA Sequence,EMBL Nucleotide Sequence Database,GenBank,Nucleic Acid Databases,RNA Databases,DNA Databanks,DNA Sequence Databases,European Molecular Biology Laboratory Nucleotide Sequence Database,Nucleic Acid Sequence Databases,RNA Sequence Databases,Bank, DNA Data,Banks, DNA Data,DNA Data Bank,DNA Databank,DNA Database,DNA Sequence Database,Data Bank, DNA,Data Banks, DNA,Databank, DNA,Databanks, DNA,Database, DNA,Database, DNA Sequence,Database, Nucleic Acid,Database, RNA,Database, RNA Sequence,Nucleic Acid Database,RNA Database,RNA Sequence Database,Sequence Database, DNA,Sequence Database, RNA,Sequence Databases, DNA,Sequence Databases, RNA
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA
D063990 Gene Ontology Sets of structured vocabularies used for describing and categorizing genes, and gene products by their molecular function, involvement in biological processes, and cellular location. These vocabularies and their associations to genes and gene products (Gene Ontology annotations) are generated and curated by the Gene Ontology Consortium. Gene Ontology Project,Gene Ontologies,Gene Ontology Projects,Ontologies, Gene,Ontology Project, Gene,Ontology Projects, Gene,Ontology, Gene,Project, Gene Ontology,Projects, Gene Ontology

Related Publications

Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
November 2023, Studies in health technology and informatics,
Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
June 2023, European review for medical and pharmacological sciences,
Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
July 2023, Zhonghua xin xue guan bing za zhi,
Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
June 2018, Oncology letters,
Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
December 2022, Journal of thoracic disease,
Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
November 2017, Oncology letters,
Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
September 2022, Medicina (Kaunas, Lithuania),
Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
March 2024, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
January 2020, Zhonghua yi xue za zhi,
Xuping Jiang, and Lili Xiao, and Xumei Jiang, and Guangsheng Li, and Zhijuan Lu
July 2019, Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation,
Copied contents to your clipboard!